Literature DB >> 35436413

Microglia and Neurodevelopmental Disorders.

John R Lukens1,2, Ukpong B Eyo1,2.   

Abstract

Mounting evidence indicates that microglia, which are the resident immune cells of the brain, play critical roles in a diverse array of neurodevelopmental processes required for proper brain maturation and function. This evidence has ultimately led to growing speculation that microglial dysfunction may play a role in neurodevelopmental disorder (NDD) pathoetiology. In this review, we first provide an overview of how microglia mechanistically contribute to the sculpting of the developing brain and neuronal circuits. To provide an example of how disruption of microglial biology impacts NDD development, we also highlight emerging evidence that has linked microglial dysregulation to autism spectrum disorder pathogenesis. In recent years, there has been increasing interest in how the gut microbiome shapes microglial biology. In the last section of this review, we put a spotlight on this burgeoning area of microglial research and discuss how microbiota-dependent modulation of microglial biology is currently thought to influence NDD progression.

Entities:  

Keywords:  Rett syndrome; autism; microbiome; microglia; neurodevelopmental disorders

Mesh:

Year:  2022        PMID: 35436413     DOI: 10.1146/annurev-neuro-110920-023056

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   15.553


  2 in total

1.  Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease.

Authors:  Mengmeng Jin; Ranjie Xu; Le Wang; Mahabub Maraj Alam; Ziyuan Ma; Sining Zhu; Alessandra C Martini; Azadeh Jadali; Matteo Bernabucci; Ping Xie; Kelvin Y Kwan; Zhiping P Pang; Elizabeth Head; Ying Liu; Ronald P Hart; Peng Jiang
Journal:  Cell Stem Cell       Date:  2022-07-07       Impact factor: 25.269

2.  An introduction to neuroimmunology.

Authors:  John R Lukens; Jessica L Williams
Journal:  Immunol Rev       Date:  2022-08-30       Impact factor: 10.983

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.